GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a remarkable shift in how we treat type 2 diabetes . These injectable therapies function to stimulating the body’s own GLP-1 process, which https://thebookmarkfree.com/story21835820/glp-1-a-major-advance-in-blood-sugar-management